Ben Parker

4.1k total citations
63 papers, 793 citations indexed

About

Ben Parker is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Ben Parker has authored 63 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Rheumatology, 22 papers in Immunology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Ben Parker's work include Systemic Lupus Erythematosus Research (35 papers), Atherosclerosis and Cardiovascular Diseases (15 papers) and Systemic Sclerosis and Related Diseases (8 papers). Ben Parker is often cited by papers focused on Systemic Lupus Erythematosus Research (35 papers), Atherosclerosis and Cardiovascular Diseases (15 papers) and Systemic Sclerosis and Related Diseases (8 papers). Ben Parker collaborates with scholars based in United Kingdom, United States and Italy. Ben Parker's co-authors include Ian N Bruce, Eoghan McCarthy, M. Yvonne Alexander, Shane McKie, Rebecca Elliott, William Turner, Philip A. Pemberton, Allen P. Yates, John A. Reynolds and Fiona L. Wilkinson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Ben Parker

55 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben Parker United Kingdom 18 438 341 132 91 86 63 793
Chris Wincup United Kingdom 17 470 1.1× 265 0.8× 115 0.9× 120 1.3× 84 1.0× 52 851
Enrica Cipriano Italy 16 501 1.1× 275 0.8× 86 0.7× 103 1.1× 116 1.3× 38 817
Laura Durcan Ireland 15 778 1.8× 549 1.6× 236 1.8× 111 1.2× 120 1.4× 33 1.3k
Toby Garrood United Kingdom 14 608 1.4× 420 1.2× 133 1.0× 85 0.9× 83 1.0× 36 1.1k
Norman Gaylis United States 16 866 2.0× 285 0.8× 60 0.5× 143 1.6× 131 1.5× 35 1.2k
A M M Eijsbouts Netherlands 14 409 0.9× 213 0.6× 65 0.5× 55 0.6× 158 1.8× 17 738
Liza Rajasekhar India 14 445 1.0× 218 0.6× 103 0.8× 85 0.9× 40 0.5× 92 792
Roberto Marini Brazil 17 443 1.0× 259 0.8× 71 0.5× 61 0.7× 99 1.2× 48 664
May Y. Choi Canada 16 467 1.1× 303 0.9× 89 0.7× 155 1.7× 124 1.4× 78 785
Meifen Zhang China 17 226 0.5× 355 1.0× 167 1.3× 78 0.9× 56 0.7× 84 1.2k

Countries citing papers authored by Ben Parker

Since Specialization
Citations

This map shows the geographic impact of Ben Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Parker more than expected).

Fields of papers citing papers by Ben Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Parker. The network helps show where Ben Parker may publish in the future.

Co-authorship network of co-authors of Ben Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Parker. A scholar is included among the top collaborators of Ben Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Parker. Ben Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reynolds, John A., Ariane L. Herrick, Sahena Haque, et al.. (2024). Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohort. Seminars in Arthritis and Rheumatism. 67. 152463–152463. 1 indexed citations
2.
Parker, Ben, et al.. (2024). Recurrent Aseptic (Mollaret) Meningitis: A Case Report. Cureus. 16(10). e72137–e72137.
3.
4.
5.
6.
Mendoza‐Pinto, Claudia, et al.. (2023). Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review update. Seminars in Arthritis and Rheumatism. 65. 152346–152346. 4 indexed citations
7.
Mendoza‐Pinto, Claudia, et al.. (2022). Predicting progression from undifferentiated connective tissue disease to definite connective tissue disease: A systematic review and meta-analysis. Autoimmunity Reviews. 21(11). 103184–103184. 13 indexed citations
8.
Reynolds, John A., Ariane L. Herrick, Sahena Haque, et al.. (2022). Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohort. Lara D. Veeken. 62(8). 2673–2682. 4 indexed citations
9.
Hum, Ryan Malcolm, et al.. (2022). A Case of IgG4-Related Disease and Membranous Nephropathy Associated with Thrombospondin Type-1 Domain-Containing 7A. SHILAP Revista de lepidopterología. 2(3). 139–144. 2 indexed citations
10.
Sutton, Emily, et al.. (2021). Lupus clinical trial eligibility in a real-world setting: results from the British Isles Lupus Assessment Group-Biologics Register (BILAG-BR). Lupus Science & Medicine. 8(1). e000513–e000513. 8 indexed citations
11.
McKie, Shane, et al.. (2021). The effects of disease activity, inflammation, depression and cognitive fatigue on resting state fMRI in systemic lupus erythematosus. Lara D. Veeken. 61(SI). SI39–SI47. 10 indexed citations
12.
McKie, Shane, et al.. (2021). The effects of disease activity on neuronal and behavioural cognitive processes in systemic lupus erythematosus. Lara D. Veeken. 61(1). 195–204. 13 indexed citations
13.
Kim, HoUng, Rieke Alten, Fraser Cummings, et al.. (2021). Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters. mAbs. 13(1). 1868078–1868078. 22 indexed citations
14.
Barton, Anne, Meghna Jani, Christine Bundy, et al.. (2020). Translating research into clinical practice: quality improvement to halve non-adherence to methotrexate. Lara D. Veeken. 60(1). 125–131. 5 indexed citations
15.
Kim, HoUng, Rieke Alten, Luisa Avedano, et al.. (2020). The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. Drugs. 80(2). 99–113. 73 indexed citations
16.
Reynolds, John A., Tracy A. Briggs, Gillian Rice, et al.. (2019). Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. Arthritis Research & Therapy. 21(1). 147–147. 19 indexed citations
17.
Parker, Ben & William Turner. (2013). Psychoanalytic/Psycho‐dynamic Psychotherapy for Children and Adolescents Who Have Been Sexually Abused: A Systematic Review. Campbell Systematic Reviews. 9(1). 3 indexed citations
18.
Parker, Ben, Philip A. Pemberton, Allen P. Yates, et al.. (2013). Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus. Annals of the Rheumatic Diseases. 73(6). 1144–1150. 76 indexed citations
19.
Parker, Ben & William Turner. (2009). PROTOCOL: Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused. Campbell Systematic Reviews. 5(1). 1–12.
20.
Parker, Ben. (2007). The relation between hostility and social support: Investigating potential mediation or moderation by trait forgiveness, attributional style, and trait empathy.. The Research Repository @ WVU (West Virginia University).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Wincup Breakdown of academic impact, for papers by Enrica Cipriano Breakdown of academic impact, for papers by Laura Durcan Breakdown of academic impact, for papers by Toby Garrood Breakdown of academic impact, for papers by Norman Gaylis Breakdown of academic impact, for papers by A M M Eijsbouts Breakdown of academic impact, for papers by Liza Rajasekhar Breakdown of academic impact, for papers by Roberto Marini Breakdown of academic impact, for papers by May Y. Choi Breakdown of academic impact, for papers by Meifen Zhang
Rankless by CCL
2026